Synchron, whose brain implant is inserted through the circulatory system, avoiding invasive brain surgery, raised a $200M Series D at a nearly $1B valuation (Ike Swetlitz/Bloomberg)
PositiveArtificial Intelligence
Synchron, whose brain implant is inserted through the circulatory system, avoiding invasive brain surgery, raised a $200M Series D at a nearly $1B valuation (Ike Swetlitz/Bloomberg)
Synchron, a company revolutionizing brain implants by using a non-invasive method through the circulatory system, has successfully raised $200 million in a Series D funding round, bringing its valuation close to $1 billion. This significant investment highlights the growing interest and confidence in innovative medical technologies that could change the way we treat neurological conditions. With this funding, Synchron is poised to advance its groundbreaking technology, potentially offering safer alternatives to traditional brain surgeries.
— via World Pulse Now AI Editorial System
